Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Short term Debt (2017 - 2024)

Historic Short term Debt for Organogenesis Holdings (ORGO) over the last 8 years, with Q3 2024 value amounting to $6.0 million.

  • Organogenesis Holdings' Short term Debt rose 877.26% to $6.0 million in Q3 2024 from the same period last year, while for Sep 2024 it was $6.0 million, marking a year-over-year increase of 877.26%. This contributed to the annual value of $5.5 million for FY2023, which is 2089.03% up from last year.
  • Organogenesis Holdings' Short term Debt amounted to $6.0 million in Q3 2024, which was up 877.26% from $5.8 million recorded in Q2 2024.
  • In the past 5 years, Organogenesis Holdings' Short term Debt registered a high of $22.5 million during Q2 2021, and its lowest value of $1.7 million during Q1 2020.
  • Moreover, its 5-year median value for Short term Debt was $5.5 million (2023), whereas its average is $7.1 million.
  • Examining YoY changes over the last 5 years, Organogenesis Holdings' Short term Debt showed a top increase of 91229.75% in 2021 and a maximum decrease of 8406.34% in 2021.
  • Quarter analysis of 5 years shows Organogenesis Holdings' Short term Debt stood at $16.7 million in 2020, then crashed by 84.06% to $2.7 million in 2021, then skyrocketed by 70.86% to $4.5 million in 2022, then rose by 20.89% to $5.5 million in 2023, then rose by 8.71% to $6.0 million in 2024.
  • Its Short term Debt was $6.0 million in Q3 2024, compared to $5.8 million in Q2 2024 and $5.5 million in Q1 2024.